1. New vaccine technology may be put to test with COVID-19 — FDA rejects Merck's 6-week Keytruda dosing schedule — Blood disorder startup Imara files for $86M IPO — See more on our front page news TRY TWO WEEKS OF OUR EMAIL NEWS HEADLINES FOR FREE
    Dismiss Notice
  2. Think you have witnessed fraud?Ask a Whistleblower Attorney -- a chance to discuss whistleblower-related legal issues with practicing whistleblower attorneys.
    Dismiss Notice

Why are so many aristada reps in the north east quitting?

Discussion in 'Alkermes' started by anonymous, Dec 11, 2019 at 2:12 AM.

Tags: Add Tags
  1. anonymous

    anonymous Guest

    what is going on up there?
     

  2. anonymous

    anonymous Guest

    Its freaking cold up there! That's what's going on. Hope that helps!
     
  3. anonymous

    anonymous Guest

    All bottom of the barrel
     
  4. anonymous

    anonymous Guest

    Ask Scott Fisher why.
     
  5. anonymous

    anonymous Guest

    They are leaving because they suck, just like all the other Aristada reps that were hired.
     
  6. anonymous

    anonymous Guest

    ........Says the Vivitrol rep that has less than 4% market share in an opioid addiction epidemic after 12 years of selling.

    Can't we just all get along??? No need to beat each other up. I'm sure we all want to win for patients and Alkermes. If you don't, please leave.
     
  7. anonymous

    anonymous Guest

    This place is crooked like Hillary! Lies deceit and list goes on.
     
  8. anonymous

    anonymous Guest

    This is why you need to ask Scott Fisher.